• Sergio Harari sul trattamento della linfangioleiomiomatosi (LAM) (in Italian)

  • Oct 25 2024
  • Length: 11 mins
  • Podcast

Sergio Harari sul trattamento della linfangioleiomiomatosi (LAM) (in Italian)

Listen for free

View show details

  • Summary

  • Il Professor Sergio Harari commenta i risultati di un trial clinico di fase 2 volto a valutare l’attivita’ e la sicurezza del farmaco nintedanib come trattamento in pazienti affetti da linfangioleiomiomatosi (LAM).

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Sergio Harari sul trattamento della linfangioleiomiomatosi (LAM) (in Italian)

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available